CA2401716A1 - Methods for promoting production of myelin by schwann cells - Google Patents

Methods for promoting production of myelin by schwann cells Download PDF

Info

Publication number
CA2401716A1
CA2401716A1 CA002401716A CA2401716A CA2401716A1 CA 2401716 A1 CA2401716 A1 CA 2401716A1 CA 002401716 A CA002401716 A CA 002401716A CA 2401716 A CA2401716 A CA 2401716A CA 2401716 A1 CA2401716 A1 CA 2401716A1
Authority
CA
Canada
Prior art keywords
pro
arg
ser
leu
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002401716A
Other languages
English (en)
French (fr)
Inventor
Emma E. Moore
Julia E. Novak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2401716A1 publication Critical patent/CA2401716A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002401716A 2000-02-29 2001-02-27 Methods for promoting production of myelin by schwann cells Abandoned CA2401716A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51522300A 2000-02-29 2000-02-29
US09/515,223 2000-02-29
PCT/US2001/006294 WO2001064240A2 (en) 2000-02-29 2001-02-27 Methods for promoting production of myelin by schwann cells

Publications (1)

Publication Number Publication Date
CA2401716A1 true CA2401716A1 (en) 2001-09-07

Family

ID=24050447

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002401716A Abandoned CA2401716A1 (en) 2000-02-29 2001-02-27 Methods for promoting production of myelin by schwann cells

Country Status (5)

Country Link
EP (1) EP1259253A2 (cg-RX-API-DMAC7.html)
JP (1) JP2003525251A (cg-RX-API-DMAC7.html)
AU (1) AU2001241816A1 (cg-RX-API-DMAC7.html)
CA (1) CA2401716A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001064240A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120392966A (zh) * 2025-07-01 2025-08-01 华中科技大学同济医学院附属协和医院 糖尿病周围神经病变靶向治疗的药物及调控雪旺细胞增殖功能的神经保护药物

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234500A1 (en) * 2001-03-26 2004-11-25 Moore Emma E. Method for inducing proliferation of retinal stem cells
JP2010509364A (ja) * 2006-11-08 2010-03-25 ザイモジェネティクス, インコーポレイテッド 創傷治癒における使用のためのil−17b
JP7214081B2 (ja) 2014-09-12 2023-01-30 ザ アドミニストレイターズ オブ ザ テューレイン エデュケイショナル ファンド 神経ミクロ生理学的システム及びこれを使用する方法
CA3023451A1 (en) 2016-05-06 2017-11-09 Exicure, Inc. Liposomal spherical nucleic acid (sna) constructs presenting antisense oligonucleotides (aso) for specific knockdown of interleukin 17 receptor mrna
WO2018201090A1 (en) 2017-04-28 2018-11-01 Exicure, Inc. Synthesis of spherical nucleic acids using lipophilic moieties

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073452A2 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
EP0839196B1 (en) * 1995-07-19 2005-05-11 Genetics Institute, LLC Human ctla-8 and uses of ctla-8-related proteins
CN1258315A (zh) * 1997-04-25 2000-06-28 津莫吉尼蒂克斯公司 哺乳动物细胞因子样因子7
AU8571198A (en) * 1997-07-16 1999-02-10 Human Genome Sciences, Inc. Interleukin-20
ES2333772T3 (es) * 1999-12-23 2010-03-01 Genentech, Inc. Polipeptidos homologos de il-17 y il-17r y sus utilizaciones terapeuticas.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120392966A (zh) * 2025-07-01 2025-08-01 华中科技大学同济医学院附属协和医院 糖尿病周围神经病变靶向治疗的药物及调控雪旺细胞增殖功能的神经保护药物

Also Published As

Publication number Publication date
EP1259253A2 (en) 2002-11-27
WO2001064240A2 (en) 2001-09-07
AU2001241816A1 (en) 2001-09-12
JP2003525251A (ja) 2003-08-26
WO2001064240A3 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
JP4441263B2 (ja) 神経変性疾患遺伝子治療剤
US8101571B2 (en) Treatment methods using NGF variants
JPH06504188A (ja) 嚢胞性線維症のための遺伝子治療
KR20180081503A (ko) 유전적 작제물
HUP0302549A2 (hu) Eritropoietin-érzékeny sejtek, szövetek és szervek védelme, helyreállítása és növelése
JP6692751B2 (ja) 新規カベオリンモジュレーターを使用する自己免疫および/または炎症疾患の治療
JP2010509181A (ja) 融合ポリペプチドを細胞へ輸送する方法
US6569419B2 (en) Methods for promoting production of myelin by Schwann cells
WO2001064240A2 (en) Methods for promoting production of myelin by schwann cells
US6759389B1 (en) Motoneuronotrophic factors
US20040234500A1 (en) Method for inducing proliferation of retinal stem cells
US7507713B2 (en) Motoneuronotrophic factor
EP0593516B1 (en) Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules
KR20240019755A (ko) 치료제의 안구 전달
CA2286558A1 (en) Ngf variants
US6627200B1 (en) Utilization of CD 137 in order to promote the proliferation of peripheral monocytes
KR100361717B1 (ko) 조골세포증식인자
Bok Gene therapy of retinal dystrophies: achievements, challenges and prospects
EP0880971B1 (en) Macrophage stimulating protein for the treatment of pathologies of the nervous system
JP3789147B2 (ja) 脊髄損傷後の神経障害に対する治療剤
US20040106550A1 (en) Remedies for arthritis deformans and remedies for rheumatoid arthritis
KR20200018955A (ko) Grp75 단백질을 유효성분으로 포함하는 신경 손상 질환 예방 또는 치료용 조성물
JP2003508545A (ja) 神経原性組成物および方法
HK1026226B (en) Isolation and use of motoneuronotrophic factors

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued